PDCD1 and viral infectious disease: Our experimental approach to in vitro blockade of the PD-1/PD-L1 pathway utilized anti-PD-L1 antibodies, as we and others have previously used in in vitro studies of PD-1 signaling in chronic human viral infections (51, 58–60, 62, 72).